Skip to main content
Equibles

MORGAN STANLEY

Position in SCLX — Scilex Holding Co

CIK 895421 NEW YORK, NY
Back to SCLX Full portfolio

Position in SCLX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$31,447
-$48,287 QoQ
Shares Held
4,032
-79.0% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 72 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 79% Shared 0% None 21%

Common Shares in SCLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 16,226,398 $19,462,430,163
2 JNJ
Johnson & Johnson
 44,808,254 $11,379,952,259
3 ABBV
AbbVie Inc.
 38,901,001 $9,789,047,884
4 MRK
Merck & Co., Inc.
 48,641,158 $6,250,388,797
5 AMGN
Amgen Inc
 13,653,692 $4,944,274,940
6 GILD
Gilead Sciences, Inc.
 24,004,354 $3,032,710,073
7 PFE
Pfizer Inc
 96,345,452 $2,319,998,477
8 BMY
Bristol Myers Squibb Co
 29,009,025 $1,671,500,010

All Filings in SCLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,447 4,032
2026-03-31 $79,734 11,973
2025-12-31 $178,189 14,606
2025-09-30 $455,704 23,156
2025-06-30 $106,335 18,054
2025-03-31 $83,382 334,886
2024-12-31 $216,151 507,404
2024-09-30 $173,812 187,907
2024-06-30 $357,151 185,054
2024-03-31 $353,803 222,520
2023-12-31 $386,398 189,412
2023-09-30 $160,548 114,679
2023-06-30 $176,319 31,656
2023-03-31 $143,038 17,444